t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma

Leuk Res. 2007 May;31(5):707-11. doi: 10.1016/j.leukres.2006.06.014. Epub 2006 Aug 2.

Abstract

Diffuse large B-cell lymphoma (DLBCL) with the 8q24 translocation is occasionally seen in the gastrointestinal tract, but has rarely been reported in the thyroid gland. We experienced two cases of primary thyroid DLBCL having t(8;14)(q24;q32). The immunophenotype and karyotype of Case 1 (66-year-old female) and Case 2 (70-year-old female) were: CD10-, CD20+, BCL-2+/add(13)(q34), t(8;14)(q24;q32) and CD10-, CD20-, CD79a+, BCL-2-/t(8;14)(q24;q32), respectively. Although long-term complete remission could be achieved in both of our patients by conventional chemotherapy with/without radiation therapy, accumulation of further such cases is necessary to develop a standard treatment protocol and also to elucidate the pathogenesis of t(8;14)(q24;q32)-positive primary thyroid DLBCL.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Chromosomes, Human, Pair 14 / genetics*
  • Chromosomes, Human, Pair 8 / genetics*
  • Female
  • Humans
  • Immunophenotyping
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / genetics*
  • Lymphoma, B-Cell / radiotherapy
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / genetics*
  • Lymphoma, Large B-Cell, Diffuse / radiotherapy
  • Neprilysin / metabolism
  • Thyroid Neoplasms / drug therapy
  • Thyroid Neoplasms / genetics*
  • Thyroid Neoplasms / radiotherapy
  • Translocation, Genetic / genetics*

Substances

  • Neprilysin